SYNERGY-NASH: Tirzepatide and metabolic steatohepatitis (MASH) SYNERGY-NASH (Loomba et al., NEJM 2024, NEJMoa2401943, PMID 38856224) is a phase 2 trial in 190 patients with metabolic steatohepatitis (MASH) and biopsy-proven stage 2 or 3 fibrosis
Why Diarrhea May Worsen or Persist After 12 Months Tolerance to nausea and appetite suppression typically improves by month 6, but tolerance to digestive side effects develops unevenly
Your Medical Weight Loss Journey At Michael Horn Plastic Surgery & Med Spa, we tailor the treatment to suit your specific needs and weight loss goals
Comprehensive health evaluation An internal medicine specialist focuses on more than just your weight
Ginger tea, peppermint water, or small sips of electrolyte solution between meals can also ease symptoms without adding calories or challenging your digestion
How much food can I eat before I feel sick on tirzepatide